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Can topical zinc accentuate tuberculin reactivity in the 
elderly? 
T. KWOK, M. D. FOTHERBY, J. COOKSON, J. F. POTTER AND C. M. CASTLEDEN 
Department of Medicine for the Elderly, Leicester General Hospital, Leicester, U.K. 
We examined the effect of topical zinc on Heaf tests in 58 elderly hospitalized patients in a double-blind study. 
Plasma zinc levels were measured. Thirty-eight subjects (66%) had negative reactions with placebo ointment. 
Fourteen of these negative responders (37%) had positive reactions with topical zinc ointment; 12 (32%) had 
weakly positive reactions and 12 remained negative. There was no significant difference in the plasma zinc 
levels between the different grades of topical zinc effect in the negative responders. Zinc deficiency is therefore 
unlikely to account for the observed booster effect of topical zinc on tuberculin reactivity. 
Introduction 
The tuberculin reaction is difficult to interpret in 
the elderly because of the waning of tuberculin sen- 
sitivity with age. Decreased cell-mediated immunity, 
a gradual loss of reactivity with time after infection 
and age related skin changes are the possible causes. 
Zinc is an important trace element that is involved 
in immunological responsiveness (1). Topical zinc has 
been shown to augment the delayed dermal hyper- 
sensitivity in malnourished children (2) an effect 
presumed to be from the correction of zinc deficiency. 
The prevalence of zinc deficiency is high among 
elderly hospitalized patients (3) and is associated 
with anergy to skin tests (4). This study examined the 
relationship between the topical zinc effect on tuber- 
culin reactivity and plasma zinc level in these 
patients. 
Methods 
Fifty elderly men (mean age 79 years) were 
recruited from the general medical (~30) and geri- 
atric wards (~28). Patients taking immunosuppres- 
sive drugs, e.g. steroids, were excluded. 
Non-fasting plasma zinc levels were measured by 
atomic absorption spectrophotometry. Heaf tests 
were performed on the volar surface of each forearm. 
Ten percent zinc sulphate was added to one of two 
identical batches of emulsifying ointment (emulsify- 
ing wax 30%, white soft paraffin 50% and liquid 
paraffin 20% by weight). The zinc and placebo oint- 
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ments were placed in pairs of identical containers 
randomly coded for each forearm for each patient by 
the pharmacist. The two ointments with identical 
appearance were applied to the corresponding test 
sites in a double-blind fashion and the sites were 
covered with Opsite. The same ointments were re- 
applied every 48 h. The Heaf tests were read at days 
3, 5 and 7. When both arms showed positive reac- 
tions before day 7, no more ointment was applied. 
The readings on day 7 were taken for analysis. A 
Grade 3 or 4 was taken to indicate a positive reac- 
tion, Grade 1 or 2 a weakly positive reaction, and 
Grade 0 a negative reaction. 
Result 
On the arm where the placebo ointment was 
applied, 15 out of the 58 subjects (26%) had a positive 
reaction, five (8%) a weakly positive reaction and 38 
(66%) a negative reaction. The positive responders 
were significantly younger than the negative respond- 
ers (76 f 6.5 vs. 80 f 6.0 years, P<O.OS). With topical 
zinc ointment, 14 of these 38 negative responders 
(37%) had a positive reaction; 12 had a weakly 
positive reaction; and 12 remained negative. The 
negative responders who remained negative with 
topical zinc were more likely to be geriatric patients 
than those who did not (PcO.01, x2 test), but there 
was no significant difference in age. One subject who 
had a Grade 3 in the placebo arm had a Grade 4 
reaction in the zinc sulphate arm. The other positive 
responders had equivalent reactions in the two arms. 
One subject had a stronger reaction in the placebo 
arm than in the zinc sulphate arm (grade 2 and grade 
1 respectively). No sensitivity rash was noted. 
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Table I The plasma zinc levels of the patient groups. 
Marked zinc effect is defined as the conversion of a negative 
reaction to a positive one 
Heaf grade Zinc effect M 
Plasma zinc level 
Mean (SD) @mol 1 - ‘) 
Positive 
Negative 
15 10.3 (1.9) 
Marked 14 9.3 (2.0) 
Mild 12 9.4 (1.9) 
No 12 9.3 (1.9) 
All 38 9.3 (1.9) 
The plasma zinc levels of the patient groups are 
shown in Table 1. There was no significant difference 
in the plasma zinc levels between positive and nega- 
tive responders (Student’s t-test) and between the 
different grades of topical zinc effect in the negative 
responders (Kruskal-Wallis test). 
Discussion 
It is likely that the majority of our subjects had 
exposure to tuberculosis in the past, and yet two- 
thirds, especially the older subjects, had negative 
Heaf tests. Our results show that topical zinc could 
boost the tuberculin reactivity in over one third of 
these negative responders. This is unlikely to be a 
non-specific effect since some subjects remained nega- 
tive despite topical zinc. A previous study showed 
that topical zinc had no direct effect on normal skin 
(5). The subjects who remained negative with topical 
zinc were mostly patients in geriatric wards, suggest- 
ing that topical zinc may be less effective in the frailer 
elderly patients. This study did not specifically exam- 
ine the enhancement in positive responders, though a 
severe (grade 4) reaction with topical zinc was 
observed. The zinc ointment was well tolerated and 
was kept in place effectively for at least 2 days by 
Opsite. 
The mechanism of the enhancing effect of topical 
zinc on delayed dermal hypersensitivity is unclear. 
Topical zinc was first shown to augment the dimin- 
ished skin test responses to Candida in a small 
number of malnourished children who had low 
plasma zinc levels. The enhancement was thought to 
be evidence of zinc deficiency (2). However, in 
another study, topical zinc augmented positive skin 
test reactions to Candida in healthy volunteers as 
well as adult hospital patients and the effect was 
independent of plasma zinc levels (5). In our study, 
the topical zinc effect in the negative responders 
was also independent of plasma zinc levels. Zinc 
deficiency is therefore unlikely to be the only expla- 
nation of this phenomenon. However, plasma zinc 
levels correlate poorly with skin zinc content (6) and 
the metabolism of zinc in skin is still unclear (7). It is 
possible that topical zinc acts by correcting actual or 
functional zinc deficiency in skin. 
The booster effect of repeated tuberculin testing 
has been used to increase the sensitivity of tuberculin 
tests in the elderly (8) but the booster rate reported 
[19.2% (S)] is smaller than that of topical zinc as 
observed in this study. There has been no comparison 
of the booster effect of repeated tuberculin testing 
with that of topical zinc. 
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